Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin beta 1 class VI pseudogene 1 (TUBB1P1) is classified as a pseudogene in the human genome, related to the protein-coding TUBB1 gene. Pseudogenes are remnants of genes that have lost their protein-coding ability or other functional capacities due to mutations. TUBB1P1 does not produce a functional protein and does not have a known biological role in normal physiology or disease. If the target of interest is a therapeutic, molecular, or biological drug target, TUBB1P1 should not be selected; instead, refer to the protein-coding TUBB1 gene[1][5][6]. In summary, TUBB1P1 is not a valid protein target, is not a receptor or enzyme, and does not contribute to druggable pathways[1][6]. If a functional role is intended (e.g., platelet biology, microtubule formation), TUBB1 (tubulin beta 1 class VI) should be referenced instead[3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin beta 1 class VI pseudogene 1 (TUBB1P1).